Kowentush Medlabs Private Limited logo

Kowentush Medlabs Private Limited

Pharmaceutical company manufacturing a variety of medicines for various therapeutic areas.
2017 | Patna, Bihar (India) | Active

Last Updated:

January 03, 2025
HomeCompanyKowentush Medlabs Private Limited

Who are the key members and board of directors at Kowentush Medlabs?

Board Members(2)

NameDesignationAppointment DateStatus
Rajnish Kumar In Director 07-Sep-2017Current
Swarnlata Devi In Director 07-Sep-2017Current

Financial Performance of Kowentush Medlabs.

Kowentush Medlabs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.42% increase. The company also saw a substantial improvement in profitability, with a 19.58% increase in profit. The company's net worth Soared by an impressive increase of 35.36%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
16.42%
Revenue from Operations
16.33%
Total Assets
17.29%
Profit or Loss
19.58%
Net Worth
35.36%
EBITDA
60.50%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹6.00 M

LenderAmountStatus

Indian Bank

Creation Date: 27 Oct 2022
₹1.10 MOpen

Others

Creation Date: 06 Feb 2019
₹4.90 MOpen

How Many Employees Work at Kowentush Medlabs?

Unlock and access historical data on people associated with Kowentush Medlabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Kowentush Medlabs

Recent activity within the organization

  • Annual General Meeting

    Kowentush Medlabs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Kowentush Medlabs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna.

    31 Mar 2024

  • Charges

    A charge with Indian Bank amounted to Rs. 1.10 M with Charge ID 100640954 was registered on 27 Oct 2022.

    27 Oct 2022

  • Charges

    A charge with Others amounted to Rs. 4.90 M with Charge ID 100251212 was registered on 06 Feb 2019.

    06 Feb 2019

  • Director Appointment

    Rajnish Kumar was appointed as a Director was appointed as a Director on 07 Sep 2017 & has been associated with this company since 7 years 4 months .

    07 Sep 2017

  • Director Appointment

    Swarnlata Devi was appointed as a Director was appointed as a Director on 07 Sep 2017 & has been associated with this company since 7 years 4 months .

    07 Sep 2017

Frequently asked questions

  • Kowentush Medlabs Private Limited was incorporated on 07 Sep 2017.

  • The authorized share capital of Kowentush Medlabs Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.

  • Currently 2 directors are associated with Kowentush Medlabs Private Limited.

    • Rajnish Kumar
    • Swarnlata Devi
  • As per Ministry of Corporate Affairs (Mca), the registered address of Kowentush Medlabs Private Limited is C/O- Parvati Mehta Building, Sandalpur Road India, Mahendru, Bihar, 800006.

  • The corporate identification number (CIN) of Kowentush Medlabs Private Limited is U24304BR2017PTC035645 and the company number is 035645 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Kowentush Medlabs Private Limited is https://www.kowentushmedlabs.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Kowentush Medlabs Private Limited has risen by 16.42%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Kowentush Medlabs Private Limited has experienced an upsurge of 35.36%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Kowentush Medlabs Private Limited amount to ₹ 6.00 M.

  • The most recent Balance Sheet for Kowentush Medlabs Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development